Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Edward Walker currently holds 242,945 shares of Marker Therapeutics, Inc. (MRKR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Edward Walker has been a net buyer of MRKR stock. They have purchased $170.8M and sold $15.9M worth of shares.
Paul Edward Walker's most recent insider trade was on Mar 10, 2026, when they purchased 242,945 shares at $11.11 per share.
Paul Edward Walker serves as Executive at Marker Therapeutics, Inc. (MRKR). They have executed 90 insider transactions totaling $186.7M over their tenure at the company.
Paul Edward Walker holds the position of Executive at Marker Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Paul Edward Walker has shown a buying trading pattern, with $170.8M in total purchases and $15.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Paul Edward Walker was on Sep 21, 2022, when they purchased $17.0M worth of ALLK shares. This transaction involved 3,386,400 shares at $5.02 per share.
Paul Edward Walker currently owns 242,945 shares of Marker Therapeutics, Inc. (MRKR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Edward Walker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Edward Walker has 90 Form 4 filings on record as an insider at Marker Therapeutics, Inc..
Set alerts for Paul Edward Walker and 40,000+ other insiders.